I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Safety, recommended dose, efficacy and immune correlates fo..:
Capucine Baldini
;
Francois-Xavier Danlos
;
Andreea Varga
...
https://doi.org/10.1186/s13046-022-02423-0. , 2022
Link:
https://doi.org/10.1186/s13046-022-02423-0
RT Journal T1
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:cc022ab82e6e4fd69d684a17c4dfa3ff&Exemplar=1&LAN=DE A1 Capucine Baldini A1 Francois-Xavier Danlos A1 Andreea Varga A1 Matthieu Texier A1 Heloise Halse A1 Severine Mouraud A1 Lydie Cassard A1 Stéphane Champiat A1 Nicolas Signolle A1 Perrine Vuagnat A1 Patricia Martin-Romano A1 Jean-Marie Michot A1 Rastislav Bahleda A1 Anas Gazzah A1 Lisa Boselli A1 Delphine Bredel A1 Jonathan Grivel A1 Chifaou Mohamed-Djalim A1 Guillaume Escriou A1 Laetitia Grynszpan A1 Amelie Bigorgne A1 Saloomeh Rafie A1 Alae Abbassi A1 Vincent Ribrag A1 Sophie Postel-Vinay A1 Antoine Hollebecque A1 Sandrine Susini A1 Siham Farhane A1 Ludovic Lacroix A1 Aurelien Parpaleix A1 Salim Laghouati A1 Laurence Zitvogel A1 Julien Adam A1 Nathalie Chaput A1 Jean-Charles Soria A1 Christophe Massard A1 Aurelien Marabelle PB BMC YR 2022 K1 Phase I K1 Dose escalation K1 Immunotherapy K1 Anti PD-1 K1 Anti-angiogenic K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://doi.org/10.1186/s13046-022-02423-0 LK http://dx.doi.org/https://doi.org/10.1186/s13046-022-02423-0 DO https://doi.org/10.1186/s13046-022-02423-0 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)